Literature DB >> 30707910

The apoA-I mimetic peptide 4F protects apolipoprotein A-I from oxidative damage.

C Roger White1, Geeta Datta1, Landon Wilson2, Mayakonda N Palgunachari1, G M Anantharamaiah3.   

Abstract

High density lipoprotein (HDL) is prone to modification by the oxidizing and chlorinating agent hypochlorite anion (OCl-). Oxidation of apolipoprotein (apo) A-I, the major protein in HDL, reduces ABCA-1 mediated cholesterol efflux and other protective responses to HDL. The apoA-I mimetic peptide 4F has been shown to undergo oxidation; however, the ability of the peptide to mediate cholesterol efflux remains intact. Here, we show that 4F protects apoA-I from hypochlorite-mediated oxidation. Mass spectral analysis of apoA-I shows that tyrosine residues that are prone to hypochlorite-mediated chlorination are protected in the presence of 4F. Furthermore, 4F enhances the cholesterol efflux ability of apoA-I to a greater extent than either 4F or apoA-I alone, even after hypochlorite oxidation. These observations suggest that apoA-I in lipid complexes may be protected by the presence of 4F, resulting in the preservation of its anti-inflammatory and anti-atherogenic properties. These studies also form the basis for the future studies of nanoparticles possessing both apoA-I and 4F.
Copyright © 2019. Published by Elsevier B.V.

Entities:  

Keywords:  ApoA-I; ApoA-I mimetic peptide; Cholesterol efflux; Hypochlorous acid; Oxidation

Mesh:

Substances:

Year:  2019        PMID: 30707910      PMCID: PMC6820518          DOI: 10.1016/j.chemphyslip.2019.01.009

Source DB:  PubMed          Journal:  Chem Phys Lipids        ISSN: 0009-3084            Impact factor:   3.329


  37 in total

Review 1.  Searching for a successful HDL-based treatment strategy.

Authors:  Srinivasa T Reddy; Mohamad Navab; G M Anantharamaiah; Alan M Fogelman
Journal:  Biochim Biophys Acta       Date:  2014-01

2.  Intestine may be a major site of action for the apoA-I mimetic peptide 4F whether administered subcutaneously or orally.

Authors:  Mohamad Navab; Srinivasa T Reddy; G M Anantharamaiah; Satoshi Imaizumi; Greg Hough; Susan Hama; Alan M Fogelman
Journal:  J Lipid Res       Date:  2011-03-28       Impact factor: 5.922

3.  Alteration in apolipoprotein A-I 22-mer repeat order results in a decrease in lecithin:cholesterol acyltransferase reactivity.

Authors:  M G Sorci-Thomas; L Curtiss; J S Parks; M J Thomas; M W Kearns
Journal:  J Biol Chem       Date:  1997-03-14       Impact factor: 5.157

4.  Interaction of apolipoprotein A-I in three different conformations with palmitoyl oleoyl phosphatidylcholine vesicles.

Authors:  M Alejandra Tricerri; Susana A Sanchez; Cristina Arnulphi; Diane M Durbin; Enrico Gratton; Ana Jonas
Journal:  J Lipid Res       Date:  2002-02       Impact factor: 5.922

Review 5.  Structure and function of HDL mimetics.

Authors:  Mohamad Navab; Ishaiahu Shechter; G M Anantharamaiah; Srinivasa T Reddy; Brian J Van Lenten; Alan M Fogelman
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-07-16       Impact factor: 8.311

6.  High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study.

Authors:  T Gordon; W P Castelli; M C Hjortland; W B Kannel; T R Dawber
Journal:  Am J Med       Date:  1977-05       Impact factor: 4.965

7.  Cholesterol metabolism and efflux in human THP-1 macrophages.

Authors:  L Kritharides; A Christian; G Stoudt; D Morel; G H Rothblat
Journal:  Arterioscler Thromb Vasc Biol       Date:  1998-10       Impact factor: 8.311

8.  Preservation of biological function despite oxidative modification of the apolipoprotein A-I mimetic peptide 4F.

Authors:  C Roger White; Geeta Datta; Amanda K W Buck; Manjula Chaddha; Gautam Reddy; Landon Wilson; Mayakonda N Palgunachari; Mohammad Abbasi; G M Anantharamaiah
Journal:  J Lipid Res       Date:  2012-05-15       Impact factor: 5.922

9.  Lipid-exchange in nanodiscs discloses membrane boundaries of cytochrome-P450 reductase.

Authors:  Carlo Barnaba; Thirupathi Ravula; Ilce G Medina-Meza; Sang-Choul Im; G M Anantharamaiah; Lucy Waskell; Ayyalusamy Ramamoorthy
Journal:  Chem Commun (Camb)       Date:  2018-06-14       Impact factor: 6.222

10.  Investigating the specific uptake of EGF-conjugated nanoparticles in lung cancer cells using fluorescence imaging.

Authors:  Honglin Jin; Jonathan F Lovell; Juan Chen; Kenneth Ng; Weiguo Cao; Lili Ding; Zhihong Zhang; Gang Zheng
Journal:  Cancer Nanotechnol       Date:  2010-11-11
View more
  6 in total

1.  HDL Mimetic Peptides.

Authors:  Jie Chen; Jiewen Liu; Baoqi Yu
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

2.  Synthetic apolipoprotein A-I mimetic peptide 4F protects hearts and kidneys after myocardial infarction.

Authors:  Roberto S Moreira; Maria C Irigoyen; Jose M C Capcha; Talita R Sanches; Paulo S Gutierrez; Margoth R Garnica; Irene de L Noronha; Lucia Andrade
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2020-01-22       Impact factor: 3.619

Review 3.  Recent advances in nanomaterials for therapy and diagnosis for atherosclerosis.

Authors:  Jun Chen; Xixi Zhang; Reid Millican; Jennifer Sherwood; Sean Martin; Hanjoong Jo; Young-Sup Yoon; Brigitta C Brott; Ho-Wook Jun
Journal:  Adv Drug Deliv Rev       Date:  2021-01-09       Impact factor: 15.470

4.  Identification of HeLa cell proteins that interact with Chlamydia trachomatis glycogen synthase using yeast two‑hybrid assays.

Authors:  Zhenjie Sun; Yuhui Sun; Yumeng Li; Xiuli Luan; Hui Chen; Haiying Wu; Bo Peng; Chunxue Lu
Journal:  Mol Med Rep       Date:  2020-01-16       Impact factor: 2.952

5.  ABCA1 is an extracellular phospholipid translocase.

Authors:  Chongren Tang; Hyun D Song; Jere P Segrest; Martin K Jones; W Sean Davidson; Stephen G Aller; Jay W Heinecke
Journal:  Nat Commun       Date:  2022-08-16       Impact factor: 17.694

6.  Apolipoprotein A-I mimetic peptides (ApoAI MP) improve oxidative stress and inflammatory responses in Parkinson's disease mice.

Authors:  Hongfang Jiang; Xue Bai
Journal:  Front Pharmacol       Date:  2022-08-19       Impact factor: 5.988

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.